OBJECTIVE: Osmotherapy with hypertonic saline ameliorates cerebral edema associated with experimental ischemic stroke. We tested the hypothesis that hypertonic saline exerts its antiedema effect by promoting an efflux of water from brain via the perivascular aquaporin-4 pool. We used mice with targeted disruption of the gene encoding alpha-syntrophin (alpha-Syn(-/-)) that lack the perivascular aquaporin-4 pool but retain the endothelial pool of this protein. DESIGN: Prospective laboratory animal study. SETTING: Research laboratory in a university teaching hospital. MEASUREMENTS AND MAIN RESULTS: Halothane-anesthetized adult male wildtype C57B/6 and alpha-Syn(-/-) mice were subjected to 90 min of transient middle cerebral artery occlusion and treated with either a continuous intravenous infusion of 0.9% saline or 3% hypertonic saline (1.5 mL/kg/hr) for 48 hr. In the first series of experiments (n = 59), increased brain water content analyzed by wet-to-dry ratios in the ischemic hemisphere of wildtype mice was attenuated after hypertonic saline (79.9% +/- 0.5%; mean +/- SEM) but not after 0.9% saline (82.3% +/- 1.0%) treatment. In contrast in alpha-Syn(-/-) mice, hypertonic saline had no effect on the postischemic edema (hypertonic saline: 80.3% +/- 0.7%; 0.9% saline: 80.3% +/- 0.4%). In the second series of experiments (n = 32), treatment with hypertonic saline attenuated postischemic blood-brain barrier disruption at 48 hr in wildtype mice but not in alpha-Syn(-/-) mice; alpha-Syn(-/-) deletion alone had no effect on blood-brain barrier integrity. In the third series of experiments (n = 34), alpha-Syn(-/-) mice treated with either hypertonic saline or 0.9% saline had smaller infarct volume as compared with their wildtype counterparts. CONCLUSIONS: These data demonstrate that 1) osmotherapy with hypertonic saline exerts antiedema effects via the perivascular pool of aquaporin-4, 2) hypertonic saline attenuates blood-brain barrier disruption depending on the presence of perivascular aquaporin-4, and 3) deletion of the perivascular pool of aquaporin-4 alleviates tissue damage after stroke, in mice subjected to osmotherapy and in nontreated mice.
OBJECTIVE: Osmotherapy with hypertonic saline ameliorates cerebral edema associated with experimental ischemic stroke. We tested the hypothesis that hypertonic saline exerts its antiedema effect by promoting an efflux of water from brain via the perivascular aquaporin-4 pool. We used mice with targeted disruption of the gene encoding alpha-syntrophin (alpha-Syn(-/-)) that lack the perivascular aquaporin-4 pool but retain the endothelial pool of this protein. DESIGN: Prospective laboratory animal study. SETTING: Research laboratory in a university teaching hospital. MEASUREMENTS AND MAIN RESULTS:Halothane-anesthetized adult male wildtype C57B/6 and alpha-Syn(-/-) mice were subjected to 90 min of transient middle cerebral artery occlusion and treated with either a continuous intravenous infusion of 0.9% saline or 3% hypertonic saline (1.5 mL/kg/hr) for 48 hr. In the first series of experiments (n = 59), increased brain water content analyzed by wet-to-dry ratios in the ischemic hemisphere of wildtype mice was attenuated after hypertonic saline (79.9% +/- 0.5%; mean +/- SEM) but not after 0.9% saline (82.3% +/- 1.0%) treatment. In contrast in alpha-Syn(-/-) mice, hypertonic saline had no effect on the postischemic edema (hypertonic saline: 80.3% +/- 0.7%; 0.9% saline: 80.3% +/- 0.4%). In the second series of experiments (n = 32), treatment with hypertonic saline attenuated postischemic blood-brain barrier disruption at 48 hr in wildtype mice but not in alpha-Syn(-/-) mice; alpha-Syn(-/-) deletion alone had no effect on blood-brain barrier integrity. In the third series of experiments (n = 34), alpha-Syn(-/-) mice treated with either hypertonic saline or 0.9% saline had smaller infarct volume as compared with their wildtype counterparts. CONCLUSIONS: These data demonstrate that 1) osmotherapy with hypertonic saline exerts antiedema effects via the perivascular pool of aquaporin-4, 2) hypertonic saline attenuates blood-brain barrier disruption depending on the presence of perivascular aquaporin-4, and 3) deletion of the perivascular pool of aquaporin-4 alleviates tissue damage after stroke, in mice subjected to osmotherapy and in nontreated mice.
Authors: J D Neely; M Amiry-Moghaddam; O P Ottersen; S C Froehner; P Agre; M E Adams Journal: Proc Natl Acad Sci U S A Date: 2001-11-20 Impact factor: 11.205
Authors: O Abe; T Okubo; N Hayashi; N Saito; N Iriguchi; I Shirouzu; Y Kojima; T Masumoto; K Ohtomo; Y Sasaki Journal: J Cereb Blood Flow Metab Date: 2000-04 Impact factor: 6.200
Authors: M Sawada; N J Alkayed; S Goto; B J Crain; R J Traystman; A Shaivitz; R J Nelson; P D Hurn Journal: J Cereb Blood Flow Metab Date: 2000-01 Impact factor: 6.200
Authors: N van Bruggen; H Thibodeaux; J T Palmer; W P Lee; L Fu; B Cairns; D Tumas; R Gerlai; S P Williams; M van Lookeren Campagne; N Ferrara Journal: J Clin Invest Date: 1999-12 Impact factor: 14.808
Authors: Elton R Migliati; Mahmood Amiry-Moghaddam; Stanley C Froehner; Marvin E Adams; Ole Petter Ottersen; Anish Bhardwaj Journal: Neurocrit Care Date: 2010-08 Impact factor: 3.210
Authors: Gulnaz Begum; Shanshan Song; Shaoxia Wang; Hanshu Zhao; Mohammad Iqbal H Bhuiyan; Eric Li; Rachel Nepomuceno; Qing Ye; Ming Sun; Michael Joseph Calderon; Donna B Stolz; Claudette St Croix; Simon C Watkins; Yinhuai Chen; Pingnian He; Gary E Shull; Dandan Sun Journal: Glia Date: 2017-09-19 Impact factor: 7.452
Authors: Jesse J Corry; Ganesh Asaithambi; Arif M Shaik; Jeffrey P Lassig; Emily H Marino; Bridget M Ho; Amy L Castle; Nilanjana Banerji; Megan E Tipps Journal: Clin Drug Investig Date: 2020-05 Impact factor: 2.859
Authors: Alexander Papangelou; Thomas J K Toung; Allan Gottschalk; Marek A Mirski; Raymond C Koehler Journal: Neurocrit Care Date: 2013-02 Impact factor: 3.210